PSNL
Personalis Inc

2,707
Mkt Cap
$761.05M
Volume
1.16M
52W High
$11.40
52W Low
$2.83
PE Ratio
-10.02
PSNL Fundamentals
Price
$8.78
Prev Close
$8.57
Open
$8.66
50D MA
$8.72
Beta
2.22
Avg. Volume
1.41M
EPS (Annual)
-$1.37
P/B
4.55
Rev/Employee
$369,493.45
News
all
press releases
Personalis Pioneers Advancement in MRD Testing with the Launch of its Real-Time Variant Tracker
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the early access launch of Real-Time Variant Tracker, a powerful new option added to its ultrasensitive NeXT...
Business Wire·1d ago
News Placeholder
More News
News Placeholder
Personalis (NASDAQ:PSNL) Trading Down 8.6% - What's Next?
Personalis (NASDAQ:PSNL) Stock Price Down 8.6% - Here's What Happened...
MarketBeat·6d ago
News Placeholder
Personalis Reports Select Preliminary Fourth Quarter and Full Year 2025 Results and Recent Highlights
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported certain unaudited preliminary financial and operational results for the fourth quarter and full...
Business Wire·6d ago
News Placeholder
Personalis (NASDAQ:PSNL) Trading 8.1% Higher - Here's Why
Personalis (NASDAQ:PSNL) Trading 8.1% Higher - Should You Buy...
MarketBeat·7d ago
News Placeholder
Personalis (NASDAQ:PSNL) Rating Lowered to Sell at Wall Street Zen
Wall Street Zen lowered Personalis from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·11d ago
News Placeholder
Smart Oncology: 5 Stocks Chasing the $317B Prize
Smart Oncology: 5 Stocks Chasing the $317B Prize Smart Oncology: 5 Stocks Chasing the $317B Prize PR Newswire VANCOUVER, BC, Dec. 31, 2025 Issued on behalf of Oncolytics Biotech Inc...
PR Newswire·14d ago
News Placeholder
Personalis, Inc. (NASDAQ:PSNL) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Personalis, Inc. (NASDAQ:PSNL - Get Free Report) have earned an average rating of "Moderate Buy" from the eight analysts that are presently covering the firm, MarketBeat reports. One...
MarketBeat·19d ago
News Placeholder
Personalis, Inc. (NASDAQ:PSNL) Given Consensus Rating of "Moderate Buy" by Brokerages
Personalis, Inc. (NASDAQ:PSNL - Get Free Report) has received an average recommendation of "Moderate Buy" from the eight research firms that are currently covering the stock, MarketBeat.com reports...
MarketBeat·19d ago
News Placeholder
Personalis (NASDAQ:PSNL) Sees Strong Trading Volume - Here's Why
Personalis (NASDAQ:PSNL) Sees Unusually-High Trading Volume - Time to Buy...
MarketBeat·25d ago
News Placeholder
Personalis Announces New Publication Applying Ultrasensitive ctDNA Testing to Monitoring Cancer Immunotherapy Response Across Solid Tumors
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the publication of a new study in Clinical Cancer Research, a journal of the American...
Business Wire·28d ago
<
1
2
...
>

Latest PSNL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.